Search Icon
Notification Icon
Ham Icon
Quick Reads icon
Quick Reads
Events & Videos icon
Events & Videos
Explore icon
Explore
Product Index icon
Product Index
eCME icon
eCME

Glycemic Outcomes with VildagliptinXR Across Diabetes Duration in Indian Young-Onset T2DM: NOVELTY Insights

calendar
21 Sep, 26
Loading PDF…
Related Topics

More From Area Of Interest
You may also like
Our Research
Understanding Post-Operative Dry Eye Disease (DED) and the Role of Sodium Hyaluronate Eye Drops (Flo...
21 Sep, 26
CiplaMedLogo
21 Sep, 26
Our Research
Dry Eye Disease: Survey on Practice Patterns and Lubricant Selection Across Disease Subtypes – Dry E...
21 Sep, 26
CiplaMedLogo
21 Sep, 26
Our Research
Glycemic Outcomes with VildagliptinXR Across Diabetes Duration in Indian Young-Onset T2DM: NOVELTY I...
21 Sep, 26
CiplaMedLogo
21 Sep, 26
Our Research
Efficacy & Safety of Torsemide & Spironolactone FDC in HF Patients: Insights from RESTORE HF Study
13 May, 26
CiplaMedLogo
13 May, 26
Our Research
Telmisartan & Amlodipine FDC for BP Control in Indian Patients with Hypertension: TACT‑India Study
17 Apr, 26
CiplaMedLogo
17 Apr, 26
Our Research
Physician Perspectives on Breath‑Actuated Inhalers: APPROACH Survey Interim Data
23 Feb, 26
CiplaMedLogo
23 Feb, 26
Latest Items